Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.54 |
| ▸ | APLNR | P35414 | 1/20 | 0.36 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.35 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22543 | 1.00 | ALDH1A1 (0.54) | ALDH1A1APLNRCYP3A4KMT2A | |
| SCHEMBL8733246 | 1.00 | ALDH1A1 (0.54) | ALDH1A1APLNRCYP3A4KMT2A | |
| SCHEMBL5902920 | 1.00 | ALDH1A1 (0.54) | ALDH1A1APLNRCYP3A4KMT2A | |
| SCHEMBL7192102 | 1.00 | ALDH1A1 (0.54) | ALDH1A1APLNRCYP3A4KMT2A | |
| SCHEMBL10507329 | 1.00 | ALDH1A1 (0.54) | ALDH1A1APLNRCYP3A4KMT2A | |
| SCHEMBL23743495 | 1.00 | ALDH1A1 (0.54) | ALDH1A1APLNRCYP3A4KMT2A | |
| SCHEMBL5903114 | 1.00 | ALDH1A1 (0.54) | ALDH1A1APLNRCYP3A4KMT2A | |
| Methane SCHEMBL10803844 | 0.98 | ALDH1A1 (0.52) | ALDH1A1APLNRCYP3A4 | |
| SCHEMBL4556661 | 0.93 | ALDH1A1 (0.48) | ALDH1A1APLNRCYP3A4 | |
| SCHEMBL1179083 | 0.93 | ALDH1A1 (0.48) | ALDH1A1APLNRCYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 31 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6887877-B2 | Compounds and methods for the treatment or prevention of Flavivirus infections | VIROCHEM PHARMA INC. (CA) | 2005-05-03 | — | — | US | claimed |
| US-20030229053-A1 | Compounds and methods for the treatment or prevention of flavivirus infections | SHIRE BIOCHEM INC. (CA) | 2003-12-11 | — | — | US | claimed |
| US-11904574-B2 | Scratch resistant film and surface coating composition | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2024-02-20 | — | — | US | disclosed |
| US-11787217-B2 | Over-laminate film and graphic laminate | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2023-10-17 | — | — | US | disclosed |
| US-20230323144-A1 | FILM AND METHOD OF PRODUCING THE SAME | 3M INNOVATIVE PROPERTIES COMPANY | 2023-10-12 | — | — | US | disclosed |
| US-20220195216-A1 | OVER-LAMINATE FILM AND GRAPHIC LAMINATE | 3M INNOVATIVE PROPERTIES COMPANY | 2022-06-23 | — | — | US | disclosed |
| US-20220185007-A1 | FILM | 3M INNOVATIVE PROPERTIES COMPANY | 2022-06-16 | — | — | US | disclosed |
| WO-2022009022-A1 | FILM AND METHOD OF PRODUCING THE SAME | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2022-01-13 | — | — | WO | disclosed |
| US-20210395965-A1 | Decorative Sheet for Road Surface, Precursor For Graphic Construct, Method of Producing Graphic Construct Sheet, And Method of Installing Decorative Sheet for Road Surface | 3M INNOVATIVE PROPERTIES COMPANY | 2021-12-23 | — | — | US | disclosed |
| US-20210061968-A1 | SCRATCH RESISTANT FILM AND SURFACE COATING COMPOSITION | 3M INNOVATIVE PROPERTIES COMPANY | 2021-03-04 | — | — | US | disclosed |
| US-10774242-B2 | Transfer sheet, and decorative film, and method for producing same | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2020-09-15 | — | — | US | disclosed |
| US-6939939-B2 | Polyurea/urethane optical material and method for making it | YOUNGER MFG. (US) | 2005-09-06 | — | — | US | disclosed |
| US-6887877-B2 | Compounds and methods for the treatment or prevention of Flavivirus infections | VIROCHEM PHARMA INC. (CA) | 2005-05-03 | — | — | US | disclosed |
| WO-2004076518-A1 | POLYUREA/URETHANE OPTICAL MATERIAL AND METHOD FOR MAKING IT | YOUNGER MFG. CO. DBA YOUNGER OPTICS (US) | 2004-09-10 | — | — | WO | disclosed |
| US-20040167311-A1 | Polyurea/urethane optical material and method for making it | YOUNGER MFG. CO. DBA YOUNGER OPTICS | 2004-08-26 | — | — | US | disclosed |
| EP-1395571-A1 | COMPOUNDS AND METHODS FOR THE TREATMENT OR PREVENTION OF FLAVIVIRUS INFECTIONS | Shire Biochem Inc. (CA) | 2004-03-10 | — | — | EP | disclosed |
| US-20030229053-A1 | Compounds and methods for the treatment or prevention of flavivirus infections | SHIRE BIOCHEM INC. (CA) | 2003-12-11 | — | — | US | disclosed |
| WO-2002100846-A1 | COMPOUNDS AND METHODS FOR THE TREATMENT OR PREVENTION OF FLAVIVIRUS INFECTIONS | SHIRE BIOCHEM INC. (CA) | 2002-12-19 | — | — | WO | disclosed |
| EP-0421215-A2 | Process for the preparation of light and exhaust gas resistant PUH elastomer fibres and films and the elastomer fibres with the corresponding composition | BAYER AG (DE) | 1991-04-10 | — | — | EP | disclosed |
| US-4879409-A | CYCLOHEXYLMETHANE DIISOCYANATES | BAYER AKTIENGESELLSCHAFT (DE) | 1989-11-07 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030229053-A1 | Compounds and methods for the treatment or prevention of flavivirus infections | HAVCR2, ZC3HAV1, MAVS | ALDH1A1 245/4885APLNR 4324/4885CYP3A4 452/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.